Fadiga
Conditions
Interventions
The target sample of the study will be 60 people. The intervention protocol will be guided by the following phases: (1) collection of socioeconomic data and current and previous clinical history of th
(2) screening and spirometry testing for lung capacity (Appendix B and Appendix C)
(3) application of the Beck Anxiety Inventory (Appendix D), the Hamilton Depression Rating Scale (HAM-D 17 items) (Appendix E) and the revised Piper Fatigue Scale (Appendix F)
(5) intervention with acupuncture sessions in the Electro Acupuncture Group and Laser Acupuncture Group
(6) reassessment with the instruments at the end of the period, in all groups. Participants selected by the inclusion criteria will be drawn to compose one of the three groups below. Group 1 - (called
E02.190.044
Sponsors
Universidade Estadual de Maringá
Universidade Estadual de Maringá
Eligibility
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 59 years; history of positive testing for SARS-Cov-2; with new or persistent symptoms since the acute phase of the disease lasting at least two months, unexplained by an alternative diagnosis; that has one or more of the following characteristics: altered spirometry parameters; fatigue score greater than 4; anxiety score equal to or greater than 11; score on the depression scale equal to or greater than 8; not having a contraindication factor for performing electroacupuncture and laseracupuncture; not being on specific clinical treatment for the post-COVID-19 syndrome; present agreement with the Free and Informed Consent Form signed in two copies; agree to participate in the proposed tests.
Exclusion criteria
Exclusion criteria: Institutionalized people; who do not present the signature of the Free and Informed Consent Form; who do not fit into the aforementioned age group; history of carcinoma; neoplasms; physical disability; motor and/or cognitive; use of metallic prostheses; pacemaker; photosensitivity history; contraindication for the use of photobiomodulation (melanin changes; history of burns); current treatment/follow-up other than usual care. Pregnant women, people with severe mental disorders, risk of suicide attempt, people with hormonal disorders, people who are under any therapeutic intervention of traditional Chinese medicine will also not be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in lung ventilatory capacity measured by spirometry, with a total expiratory volume (FVC) index above 60%. Data were collected one week before the start of the intervention, after the end of the sixth (third week) and 12th session (sixth week) after the start of the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes evaluated will be the Beck Anxiety Inventory score, with a score greater than or equal to 11, the Hamilton Depression Rating Scale HAM-D-17, with a score greater than or equal to 8 and the Piper Fatigue Scale, with a score above 4. Data were collected one week before the start of the intervention, after the end of the sixth (third week) and 12th session (sixth week) after the start of the intervention. | — |
Countries
Brazil
Contacts
Public ContactDrielly Salvador
Universidade Estadual de Maringá
Outcome results
None listed